Primary |
Contraception |
65.4% |
Off Label Use |
9.6% |
Endometriosis |
3.0% |
Oral Contraception |
3.0% |
Migraine |
2.8% |
Menstrual Cycle Management |
2.0% |
Dysmenorrhoea |
1.8% |
Asthma |
1.5% |
Hormone Therapy |
1.3% |
Menstruation Irregular |
1.3% |
Ovarian Cyst |
1.3% |
Depression |
1.0% |
Bipolar Disorder |
0.8% |
Gastritis |
0.8% |
Hypothyroidism |
0.8% |
Menorrhagia |
0.8% |
Migraine Prophylaxis |
0.8% |
Nasopharyngitis |
0.8% |
Pain |
0.8% |
Von Willebrand's Disease |
0.8% |
|
Unintended Pregnancy |
32.2% |
Drug Ineffective |
17.5% |
Product Quality Issue |
14.4% |
Metrorrhagia |
11.7% |
Drug Ineffective For Unapproved Indication |
2.8% |
Menorrhagia |
2.8% |
Abnormal Withdrawal Bleeding |
2.5% |
Dysmenorrhoea |
2.1% |
Inappropriate Schedule Of Drug Administration |
1.8% |
Menstruation Irregular |
1.8% |
Headache |
1.5% |
Abortion Spontaneous |
1.2% |
Acne |
1.2% |
Circumstance Or Information Capable Of Leading To Medication Error |
0.9% |
Malaise |
0.9% |
Nausea |
0.9% |
Pain |
0.9% |
Pregnancy On Oral Contraceptive |
0.9% |
Vaginal Haemorrhage |
0.9% |
Weight Decreased |
0.9% |
|
Secondary |
Contraception |
41.7% |
Off Label Use |
18.1% |
Menstrual Cycle Management |
5.4% |
Endometriosis |
4.4% |
Oral Contraception |
3.9% |
Migraine |
3.4% |
Dysmenorrhoea |
2.9% |
Menstruation Irregular |
2.5% |
Ovarian Cyst |
2.5% |
Cholecystitis |
2.0% |
Cholelithiasis |
2.0% |
Gastritis |
1.5% |
Hormone Therapy |
1.5% |
Menorrhagia |
1.5% |
Nasopharyngitis |
1.5% |
Von Willebrand's Disease |
1.5% |
Hormone Replacement Therapy |
1.0% |
Menstrual Discomfort |
1.0% |
Migraine Prophylaxis |
1.0% |
Pain |
1.0% |
|
Unintended Pregnancy |
25.8% |
Drug Ineffective |
15.1% |
Metrorrhagia |
12.9% |
Product Quality Issue |
10.8% |
Drug Ineffective For Unapproved Indication |
9.7% |
Vomiting |
3.2% |
Acne |
2.2% |
Circumstance Or Information Capable Of Leading To Medication Error |
2.2% |
Headache |
2.2% |
Irritable Bowel Syndrome |
2.2% |
Malaise |
2.2% |
Menstruation Irregular |
2.2% |
Premenstrual Syndrome |
2.2% |
Abdominal Discomfort |
1.1% |
Hypothyroidism |
1.1% |
Hypoxia |
1.1% |
Menorrhagia |
1.1% |
Mood Altered |
1.1% |
Mood Swings |
1.1% |
Nausea |
1.1% |
|
Concomitant |
Contraception |
24.0% |
Menstruation Irregular |
12.0% |
Oral Contraception |
12.0% |
Acne |
8.0% |
Hypersensitivity |
8.0% |
Hypertonic Bladder |
8.0% |
Dyspepsia |
4.0% |
Insomnia |
4.0% |
Menstrual Cycle Management |
4.0% |
Multiple Sclerosis |
4.0% |
Product Used For Unknown Indication |
4.0% |
Prophylaxis |
4.0% |
Ulcer |
4.0% |
|
Pulmonary Embolism |
27.3% |
Blood Bilirubin Increased |
9.1% |
Heart Rate Increased |
9.1% |
Hernia |
9.1% |
Injection Site Pain |
9.1% |
Injury |
9.1% |
Pain |
9.1% |
Pain In Extremity |
9.1% |
Vomiting |
9.1% |
|